Statistics for Pharming Group N.V. (id:68 PHARM)

Valuation metrics

Market cap

497.88M

Enterprise value

305.86M

Trailing P/E (ttm)

57.15

Forward P/E

-71.35

PEG ratio

-71.35

Price/Sales (ttm)

1.74

Price/Book (mrq)

1.63

Enterprise Value/Revenue

1.14

Enterprise Value/EBITDA

-106.05

Overview

Shares outstanding

678.35M

Float

500.40M

Shares short

% Held by insiders

0.02%

% Held by institutions

0.16%

Average volume (10 days)

3.73M

Average volume (90 days)

Price summary

52-Week low

0.65

52-Week high

1.22

52-Week change

-53.52%

Beta

0.81

50-Day moving average

0.75

200-Day moving average

0.84

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

March 05th, 2013

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-6.24%

Operating margin

5.49%

Operational effectiveness

Return on assets

-1.38%

Return on equity

-8.18%

Income statement

Revenue (ttm)

0.44

Revenue per share (ttm)

0.44

Quarterly revenue growth (yoy)

Gross profit (ttm)

220.10M

EBITDA

-2,884,126.00

Net income to common (ttm)

-16,815,109.00

Diluted EPS (ttm)

-0.03

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

162.05M

Total cash per share (mrq)

0.33

Total debt (mrq)

119.90M

Total Debt/Equity (mrq)

56.28

Current ratio (mrq)

353.50%

Book value per share (mrq)

0.44

Cash flow

Cash flow statement

425.50K

Levered free cash flow (LFCF)

4.24M